Description: Life insurance with LTC features is exciting business to produce, but the complex for a valuation actuary at year-end. This session will discuss setting morbidity and policyholder behavior assumptions for principles-based reserving and cash flow testing more generally. We will review considerations for GAAP reserving for hybrid products. We will highlight the interaction of assumptions whose risks offset (mortality, morbidity, lapse, and more) and how the valuation actuary may think of these in sensitivity testing and setting prudent estimates. Panelists will draw from the 2022 Academy of Actuaries Combination Product Valuation Practice Note.Finally, we will discuss reserve assumption setting in light of public-private LTC legislation (e.g. Washington Cares), which inspired sales of hybrid life and LTC products in the individual and worksite markets.

Description: This session will focus on hot topics at an intermediate level for actuaries supporting year-end financial reporting on orange blank. We will discuss responsibilities and considerations when issuing statement of actuarial opinion. We will also discuss capital management for health insurers and important considerations beyond capitalization.

Description: Dana M. Peterson, chief economist for the Conference Board, has established herself as a visionary, and the go to expert providing insightful analysis and predictions to corporations, associations, and government organizations looking for clarity and foresight into how economic drivers might impact their businesses in the short- and long-term. With over two decades of experience in the field, she serves as the globally recognized think tank’s public face and primary spokesperson on all things related to the economy.

Description: The insurance industry recently adopted two significant accounting changes. Good risk management requires a solid understanding of new risks as well as a proper set of controls. Learn how internal audit can help actuaries better understand arising risks and build a more robust control framework.

Description: In this talk, we look at two behavioral aspects: from end customers perspective and through the lens of underwriters. We will examine simple rules to improve the insurance underwriting decision to judge whether a risk is insurable and whether they have impact on increasing underwriting decision quality.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: The Society of Actuaries will be offering this webinar series intended to educate and investigate aspects of life insurance, annuity, and long-term care product tax compliance. Developed by the Taxation Section, participants will be brought up to date on recent Internal Revenue Service (IRS) guidance and learn about the newest tax issues related to product design and administration. Legal, IRS and product development experts will provide vital insights into the challenges of developing and administering products within the requirements of the Internal Revenue Code (IRC) and allow ample opportunities for questions and information exchange. This session will provide an intense introduction to the basics of product taxation, with a focus on life insurance and the requirements of Section 7702A.

Description: Exploring the SOA Exam Pathway in India

Description: Defining fairness for life insurance processes is complex and challenging as well as subjective. This webcast will be a discussion of the challenges and opportunities presented as our profession rethinks fairness in the context of processes involved in developing and managing life insurance, especially risk classification.

Description: With LDTI in the rear-view mirror for 2023 adopters, and 2025 adopters still working to meet the requirements before reporting on an LDTI basis for the first time at year-end 2025, there remain many opportunities and challenges for all companies subject to LDTI. These may include further enhancements to modeling, improvements in end-to-end processes (such as automation and reducing the close financial timeline), development of robust management reporting and analysis frameworks, and enhancements to financial planning and analysis under LDTI.